pA2 online
© Copyright 2004 The British Pharmacological Society

075P University of Bath
Summer Meeting July 2004

The putative palmitoylation site (cysteine 361) within human proteinase-activated receptor-2 (hPAR2) regulates receptor agonist sensitivity and cell surface expression

A.M. Botham, A. H. Morice and S. J. Compton. Respiratory Medicine, Division of Academic Medicine and Cell and Molecular Medicine, The Post Graduate Medical Institute in association with the Hull York Medical School

Print abstract



Search PubMed for:



Botham AM
Morice AH
Compton SJ

Proteinase-activated receptors are a novel class of G-protein coupled receptors activated by proteolytic cleavage of the N-terminal domain. The proteinase revealed tethered ligand then binds to and activates the receptor. Recently, we have shown that the post-translational modification, N-linked glycosylation has a profound effect on hPAR2 receptor function (Compton et al., 2002). Therefore we have investigated the role of another post-translational modification, palmitoylation, in regulating hPAR2 function.

Employing site directed mutagenesis we have mutated the putative palmitoylation site (C361) within
hPAR 2 and expressed the mutant receptor (hPAR2C361A) in the Chinese Hamster Ovary PRO5 cell line. FACS analysis was used to compare cell surface expression of hPAR2C361A mutant and wild-type hPAR2 (wt-hPAR2) receptor expressing cell lines. hPAR2C361A consistently displayed an ~2-fold greater cell surface expression compared to wt-hPAR2.

Intracellular Ca2+ signalling was then employed to compare the functional activity between wt-hPAR2 and hPAR2C361A using cell lines with matched cell surface expression. hPAR2C361A displayed a striking decrease in agonist sensitivity towards trypsin with EC50 values 4-fold greater than that of wt-hPAR2 (41 ± 4 nM compared to 11 ± 4 nM, mean ± sem) and 6-fold greater EC50 values for the selective hPAR2 activating peptide SLIGKV-NH 2 (104 ± 2 nM compared to 16 ± 5 nM). In addition, hPAR2C361A displayed a decrease of ~50% and ~66% in maximal response to trypsin and SLIGKV-NH2 respectively, compared to that of wt-PAR2.

Thus, palmitoylation may play an important role in regulating hPAR2 function.

Compton, S.J. et al. (2002). Biochem J, 368, 495-505